n(g),n(g')-dimethyl-l-arginine has been researched along with Stroke in 36 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Increased levels of asymmetric dimethylarginine (ADMA) have been observed in patients with acute ischemic stroke." | 9.19 | Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke. ( Li, X; Ma, JP; Wang, JZ; Wang, L; Wu, CJ; Xia, XS, 2014) |
| "Based on the hypothesis that mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) are caused by impaired vasodilation in an intracerebral artery, the authors evaluated the effects of administering l-arginine, a nitric oxide precursor." | 9.11 | L-arginine improves the symptoms of strokelike episodes in MELAS. ( Akita, Y; Fujimoto, S; Koga, Y; Matsuishi, T; Nishioka, J; Povalko, N; Tanabe, Y; Yatsuga, S, 2005) |
| "The aim of this study was to evaluate serum ADMA levels, which are an indicator of endothelial dysfunction of the renal functions in patients with acute ischemic stroke, and to determine whether there is a possible correlation between ADMA and NO levels and the l-arginine-to-ADMA ratio." | 7.91 | Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke. ( Abusoglu, S; Akbulut, D; Bal, C; Celik, HT; Ercan, M; Güzel, I; Mungan, S; Oguz, EF; Yilmaz, FM, 2019) |
| "Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been reported to be associated with endothelial dysfunction, inflammation, and oxidative stress in multiple cardiovascular diseases." | 7.79 | Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. ( Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC, 2013) |
| "We hypothesise that asymmetric and symmetric dimethylarginine (ADMA, SDMA) are released in cerebrospinal fluid (CSF) due to ischemia-induced proteolysis and that CSF dimethylarginines are related to stroke severity." | 7.75 | Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. ( Brouns, R; De Deyn, PP; Marescau, B; Possemiers, I; Sheorajpanday, R, 2009) |
| " Although asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, is associated with atherosclerotic disease, there has been no report on association of ADMA with ischemic stroke." | 7.71 | Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. ( Lee, SC; Yoo, JH, 2001) |
| "Increased levels of asymmetric dimethylarginine (ADMA) have been observed in patients with acute ischemic stroke." | 5.19 | Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke. ( Li, X; Ma, JP; Wang, JZ; Wang, L; Wu, CJ; Xia, XS, 2014) |
| "Based on the hypothesis that mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) are caused by impaired vasodilation in an intracerebral artery, the authors evaluated the effects of administering l-arginine, a nitric oxide precursor." | 5.11 | L-arginine improves the symptoms of strokelike episodes in MELAS. ( Akita, Y; Fujimoto, S; Koga, Y; Matsuishi, T; Nishioka, J; Povalko, N; Tanabe, Y; Yatsuga, S, 2005) |
| "The aim of this study was to evaluate serum ADMA levels, which are an indicator of endothelial dysfunction of the renal functions in patients with acute ischemic stroke, and to determine whether there is a possible correlation between ADMA and NO levels and the l-arginine-to-ADMA ratio." | 3.91 | Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke. ( Abusoglu, S; Akbulut, D; Bal, C; Celik, HT; Ercan, M; Güzel, I; Mungan, S; Oguz, EF; Yilmaz, FM, 2019) |
| "Guanidino compounds, including l-homoarginine (l-hArg), symmetric dimethylarginine (SDMA), asymmetric dimethylarginine (ADMA) and l-arginine (l-Arg) are associated with mortality, fatal strokes, stroke incidence, and atherosclerosis." | 3.91 | Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA ( Atzler, D; Böger, RH; Choe, CU; Cordts, K; Gerloff, C; Grant, PJ; Grzybowski, R; Hornig, S; Lezius, S; Lüneburg, N; Magnus, T; Neu, A; Schwedhelm, E; Thomalla, G, 2019) |
| " Markers of endothelial dysfunction (asymmetric dimethylarginine, ADMA) and inflammation (lipoprotein-associated phospholipase A2, Lp-PLA2) were measured." | 3.85 | Distinct Roles of Endothelial Dysfunction and Inflammation in Intracranial Atherosclerotic Stroke. ( Bang, OY; Cho, YH; Chung, CS; Chung, JW; Kim, GM; Lee, KH; Moon, GJ; Oh, MJ, 2017) |
| "Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been reported to be associated with endothelial dysfunction, inflammation, and oxidative stress in multiple cardiovascular diseases." | 3.79 | Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. ( Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC, 2013) |
| "In the present study, we tested whether a novel genetic variant in dimethylarginine dimethylaminohydrolase 1 (DDAH1), an important ADMA hydrolyzing gene, was associated with stroke and coronary heart disease (CHD) susceptibility in the Chinese Han population." | 3.76 | A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. ( Ding, H; Hui, R; Lu, Z; Shaffer, JR; Wang, DW; Wang, H; Wang, X; Wu, B; Yan, J, 2010) |
| "We hypothesise that asymmetric and symmetric dimethylarginine (ADMA, SDMA) are released in cerebrospinal fluid (CSF) due to ischemia-induced proteolysis and that CSF dimethylarginines are related to stroke severity." | 3.75 | Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. ( Brouns, R; De Deyn, PP; Marescau, B; Possemiers, I; Sheorajpanday, R, 2009) |
| " Although asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, is associated with atherosclerotic disease, there has been no report on association of ADMA with ischemic stroke." | 3.71 | Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. ( Lee, SC; Yoo, JH, 2001) |
| "Stroke is a devastating condition encompassing a wide range of pathophysiological entities that include thrombosis, hemorrhage, and embolism." | 2.46 | Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. ( Christenson, RH; Saenger, AK, 2010) |
| "Ischemic acute stroke is a leading cause for mortality and invalidity in recent years." | 1.42 | ADMA--a Possible Marker for Early Therapeutic Outcome in Acute Stroke. ( Manolov, VE; Petrova, JJ; Tzatchev, KN; Vasilev, VG; Zlatareva, DK, 2015) |
| "Patients with AF-recurrence were older, had a higher proportion of hypertension and long-standing persistent AF." | 1.40 | Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation. ( Alasady, M; Chakrabarty, A; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (27.78) | 29.6817 |
| 2010's | 26 (72.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, E | 1 |
| Ruiz-Canela, M | 1 |
| Hu, FB | 1 |
| Clish, CB | 1 |
| Corella, D | 1 |
| Salas-Salvadó, J | 1 |
| Hruby, A | 1 |
| Fitó, M | 1 |
| Liang, L | 1 |
| Toledo, E | 1 |
| Ros, E | 1 |
| Estruch, R | 1 |
| Gómez-Gracia, E | 1 |
| Lapetra, J | 1 |
| Arós, F | 1 |
| Romaguera, D | 1 |
| Serra-Majem, L | 1 |
| Guasch-Ferré, M | 1 |
| Wang, DD | 1 |
| Martínez-González, MA | 1 |
| Chung, JW | 1 |
| Oh, MJ | 1 |
| Cho, YH | 1 |
| Moon, GJ | 1 |
| Kim, GM | 1 |
| Chung, CS | 1 |
| Lee, KH | 1 |
| Bang, OY | 1 |
| Ercan, M | 1 |
| Mungan, S | 1 |
| Güzel, I | 1 |
| Celik, HT | 1 |
| Bal, C | 1 |
| Abusoglu, S | 1 |
| Akbulut, D | 1 |
| Oguz, EF | 1 |
| Yilmaz, FM | 1 |
| Cordts, K | 1 |
| Grzybowski, R | 1 |
| Lezius, S | 1 |
| Lüneburg, N | 3 |
| Atzler, D | 2 |
| Neu, A | 1 |
| Hornig, S | 1 |
| Böger, RH | 5 |
| Gerloff, C | 2 |
| Magnus, T | 2 |
| Thomalla, G | 1 |
| Schwedhelm, E | 4 |
| Grant, PJ | 2 |
| Choe, CU | 2 |
| Chen, S | 1 |
| Li, N | 2 |
| Deb-Chatterji, M | 1 |
| Dong, Q | 1 |
| Kielstein, JT | 2 |
| Weissenborn, K | 3 |
| Worthmann, H | 2 |
| Martens-Lobenhoffer, J | 1 |
| Joumaah, M | 1 |
| Lichtinghagen, R | 1 |
| Hecker, H | 1 |
| Ehrenreich, H | 1 |
| Bode-Böger, SM | 1 |
| Chao, TF | 1 |
| Lu, TM | 2 |
| Lin, YJ | 1 |
| Tsao, HM | 1 |
| Chang, SL | 1 |
| Lo, LW | 1 |
| Hu, YF | 1 |
| Tuan, TC | 1 |
| Hsieh, MH | 1 |
| Chen, SA | 1 |
| Nishiyama, Y | 4 |
| Otsuka, T | 4 |
| Ueda, M | 4 |
| Inagaki, H | 1 |
| Muraga, K | 2 |
| Abe, A | 4 |
| Kawada, T | 1 |
| Katayama, Y | 4 |
| Xia, XS | 1 |
| Li, X | 1 |
| Wang, L | 1 |
| Wang, JZ | 1 |
| Ma, JP | 1 |
| Wu, CJ | 1 |
| Lim, HS | 2 |
| Willoughby, SR | 2 |
| Schultz, C | 2 |
| Chakrabarty, A | 1 |
| Alasady, M | 2 |
| Lau, DH | 2 |
| Roberts-Thomson, KC | 1 |
| Worthley, MI | 2 |
| Young, GD | 2 |
| Sanders, P | 2 |
| Lieb, W | 1 |
| Zeller, T | 1 |
| Chen, MH | 1 |
| Maas, R | 2 |
| Carter, AM | 1 |
| Xanthakis, V | 1 |
| Glazer, NL | 1 |
| Seshadri, S | 1 |
| Ikram, MA | 1 |
| Longstreth, WT | 1 |
| Fornage, M | 1 |
| König, IR | 1 |
| Loley, C | 1 |
| Ojeda, FM | 1 |
| Schillert, A | 1 |
| Wang, TJ | 1 |
| Sticht, H | 1 |
| Kittel, A | 1 |
| König, J | 1 |
| Benjamin, EJ | 1 |
| Sullivan, LM | 1 |
| Bernges, I | 1 |
| Anderssohn, M | 1 |
| Ziegler, A | 1 |
| Gieger, C | 1 |
| Illig, T | 1 |
| Meisinger, C | 1 |
| Wichmann, HE | 1 |
| Wild, PS | 1 |
| Schunkert, H | 1 |
| Psaty, BM | 1 |
| Wiggins, KL | 1 |
| Heckbert, SR | 1 |
| Smith, N | 1 |
| Lackner, K | 1 |
| Lunetta, KL | 1 |
| Blankenberg, S | 1 |
| Erdmann, J | 1 |
| Munzel, T | 1 |
| Vasan, RS | 1 |
| Zhang, Y | 1 |
| Fan, D | 1 |
| Zhang, N | 1 |
| Willeit, P | 1 |
| Freitag, DF | 1 |
| Laukkanen, JA | 1 |
| Chowdhury, S | 1 |
| Gobin, R | 1 |
| Mayr, M | 1 |
| Di Angelantonio, E | 1 |
| Chowdhury, R | 1 |
| Petrova, JJ | 1 |
| Manolov, VE | 1 |
| Vasilev, VG | 1 |
| Zlatareva, DK | 1 |
| Tzatchev, KN | 1 |
| Solovyeva, LN | 1 |
| Shmonin, AA | 1 |
| Emanuel, YV | 1 |
| Stolyarov, MS | 1 |
| Bondareva, EA | 1 |
| Lazareva, NM | 1 |
| Kholopova, IV | 1 |
| Blinova, TV | 1 |
| Kharitonova, TV | 1 |
| Lapin, SV | 1 |
| Emanuel, VL | 1 |
| Melnikova, EV | 1 |
| Haghikia, A | 2 |
| Yanchev, GR | 1 |
| Kayacelebi, AA | 1 |
| Hanff, E | 1 |
| Bledau, N | 1 |
| Widera, C | 1 |
| Sonnenschein, K | 1 |
| Bauersachs, J | 1 |
| Bavendiek, U | 1 |
| Tsikas, D | 1 |
| Brouns, R | 1 |
| Marescau, B | 1 |
| Possemiers, I | 1 |
| Sheorajpanday, R | 1 |
| De Deyn, PP | 1 |
| Leypoldt, F | 1 |
| Gelderblom, M | 1 |
| von Leitner, EC | 1 |
| Sydow, K | 1 |
| Saenger, AK | 1 |
| Christenson, RH | 1 |
| Katsura, K | 2 |
| Nagayama, H | 2 |
| Ding, H | 1 |
| Wu, B | 1 |
| Wang, H | 1 |
| Lu, Z | 1 |
| Yan, J | 1 |
| Wang, X | 1 |
| Shaffer, JR | 1 |
| Hui, R | 1 |
| Wang, DW | 1 |
| Sharma, P | 1 |
| Bentley, P | 1 |
| Mamatha, SN | 1 |
| Nagaraja, D | 1 |
| Philip, M | 1 |
| Christopher, R | 1 |
| Chung, MY | 1 |
| Lin, CC | 1 |
| Hsu, CP | 1 |
| Lin, SJ | 1 |
| von Holten, RA | 1 |
| Töpper, RF | 1 |
| Gan, C | 1 |
| Leong, DP | 1 |
| Brooks, AG | 1 |
| Kistler, PM | 1 |
| Kalman, JM | 1 |
| Faraci, FM | 1 |
| Lentz, SR | 1 |
| Tsuda, K | 1 |
| Nishio, I | 1 |
| Valkonen, VP | 1 |
| Laaksonen, R | 1 |
| Koga, Y | 1 |
| Akita, Y | 1 |
| Nishioka, J | 1 |
| Yatsuga, S | 1 |
| Povalko, N | 1 |
| Tanabe, Y | 1 |
| Fujimoto, S | 1 |
| Matsuishi, T | 1 |
| Wanby, P | 1 |
| Teerlink, T | 1 |
| Brudin, L | 1 |
| Brattström, L | 1 |
| Nilsson, I | 1 |
| Palmqvist, P | 1 |
| Carlsson, M | 1 |
| Leong, T | 1 |
| Zylberstein, D | 1 |
| Graham, I | 1 |
| Lissner, L | 1 |
| Ward, D | 1 |
| Fogarty, J | 1 |
| Bengtsson, C | 1 |
| Björkelund, C | 1 |
| Thelle, D | 1 |
| Yoo, JH | 1 |
| Lee, SC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Correlation Of CoAGulation Biomarkers and Atrial Fibrillation Burden in Patients Post Catheter Ablation: the COAG-AF Pilot Study[NCT04947657] | 20 participants (Anticipated) | Observational | 2021-09-22 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for n(g),n(g')-dimethyl-l-arginine and Stroke
| Article | Year |
|---|---|
Asymmetric dimethyarginine as marker and mediator in ischemic stroke.
Topics: Animals; Arginine; Biomarkers; Brain Ischemia; Cerebrovascular Circulation; Enzyme Inhibitors; Human | 2012 |
Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies.
Topics: Arginine; Cardiovascular Diseases; Humans; Odds Ratio; Prospective Studies; Stroke | 2015 |
Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Arginine; Biomarkers; Diffusion Magnetic Resonance I | 2010 |
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Dise | 2004 |
Asymmetric dimethylarginine (ADMA) and acute vascular events.
Topics: Acute Disease; Angina Pectoris; Arginine; Cardiovascular Diseases; Humans; Myocardial Infarction; St | 2004 |
4 trials available for n(g),n(g')-dimethyl-l-arginine and Stroke
| Article | Year |
|---|---|
Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Arginine; Double-Blind Method; Drug Therapy, Combination; Er | 2013 |
Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke.
Topics: Aged; Arginine; Blood Chemical Analysis; Brain Ischemia; Dietary Supplements; Female; Folic Acid; Fo | 2014 |
Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Atorvastatin; Brain Ischemia; Cholesterol, LDL; | 2011 |
L-arginine improves the symptoms of strokelike episodes in MELAS.
Topics: Administration, Oral; Adolescent; Adult; Amino Acids; Arginine; Cerebral Arteries; Child; Child, Pre | 2005 |
27 other studies available for n(g),n(g')-dimethyl-l-arginine and Stroke
| Article | Year |
|---|---|
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; C | 2017 |
Distinct Roles of Endothelial Dysfunction and Inflammation in Intracranial Atherosclerotic Stroke.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Arginine; Biomarkers; Endothelium; Female; Hum | 2017 |
Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
Topics: Aged; Aged, 80 and over; Arginine; Brain Ischemia; Female; Humans; Male; Middle Aged; Nitric Oxide; | 2019 |
Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA
Topics: Aged; Arginine; Biomarkers; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cross-Sectional Stud | 2019 |
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cardiovascular Diseases; Coronary Angiograph | 2013 |
Asymmetric dimethylarginine is related to the predicted stroke risk in middle-aged Japanese men.
Topics: Adult; Aged; Arginine; Humans; Linear Models; Male; Middle Aged; Retrospective Studies; Risk Factors | 2014 |
The asymmetric dimethylarginine level is associated with the predicted stroke risk in Japanese women.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Cross-Sectional Studies; Female; Follow-Up Studies; Humans | 2014 |
Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Catheter Ablation; Electrocardiography; Endothelium | 2014 |
Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.
Topics: Adult; Aged; Amidohydrolases; Arginine; Binding Sites; Cohort Studies; Female; Genetic Loci; Genome- | 2014 |
[The relationship between serum asymmetric dimethylarginine and ABCD2 score in transient ischemic attack patients].
Topics: Arginine; Case-Control Studies; Cerebral Infarction; Humans; Ischemic Attack, Transient; Risk Factor | 2014 |
ADMA--a Possible Marker for Early Therapeutic Outcome in Acute Stroke.
Topics: Aged; Arginine; Biomarkers; Female; Humans; Male; Middle Aged; Stroke; Thrombolytic Therapy | 2015 |
[THE CLINICAL LABORATORY MARKERS OF ATHEROSCLEROSIS IN PATIENTS WITH ATHEROTHROMBOTIC STROKE].
Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Stenosis | 2015 |
The role of L-arginine/L-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients.
Topics: Aorta; Arginine; Atherosclerosis; Endothelium, Vascular; Female; Homoarginine; Humans; Male; Middle | 2017 |
Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity.
Topics: Aged; Arginine; Brain Ischemia; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Strok | 2009 |
Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.
Topics: Amidohydrolases; Animals; Arginine; Brain; Endothelium, Vascular; Genotype; Infarction, Middle Cereb | 2009 |
Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
Topics: Age Factors; Aged; Arginine; Biomarkers; Blood Glucose; Brain Ischemia; Cholesterol, LDL; Dyslipidem | 2010 |
A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease.
Topics: Aged; Amidohydrolases; Arginine; Asian People; Binding Sites; Biomarkers; Case-Control Studies; Cell | 2010 |
Down but not out: candidate gene-based studies still have value in a world dominated by whole genome approaches.
Topics: Amidohydrolases; Arginine; Asian People; Biomarkers; China; Coronary Artery Disease; Evidence-Based | 2010 |
Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population.
Topics: Adolescent; Adult; Analysis of Variance; Arginine; Biomarkers; Brain Ischemia; Case-Control Studies; | 2011 |
Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Albuminuria; Arginine; Biomarkers; Chi-Square Distribution; Chromatography, | 2011 |
Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Brain Ischemia; Chromatography, Liquid; Female; Follo | 2012 |
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.
Topics: Aged; Antithrombin III; Arginine; Atrial Fibrillation; Catheter Ablation; CD40 Ligand; Enzyme Inhibi | 2013 |
Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction.
Topics: Arginine; Cerebrovascular Circulation; DNA Methylation; Homocysteine; Humans; Hyperhomocysteinemia; | 2004 |
Homocysteine, vitamin B6, and endothelial dysfunction in circulatory disorders.
Topics: Arginine; C-Reactive Protein; Endothelium, Vascular; Homocysteine; Humans; Nitric Oxide; Pyridoxal P | 2004 |
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.
Topics: Acute Disease; Aged; Arginine; Biomarkers; Cerebral Hemorrhage; Cerebral Infarction; Enzyme Inhibito | 2006 |
Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
Topics: Adult; Arginine; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Longit | 2008 |
Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Topics: Aged; Aged, 80 and over; Arginine; Cerebral Infarction; Chromatography, High Pressure Liquid; Enzyme | 2001 |